Zerga, M. “Bispecific Antibodies in the Treatment of relapsed/Refractory Diffuse Large B Cell Lymphoma. Role of Epcoritamab”. Journal of Hematology, vol. 29, no. 1, June 2025, pp. 11-21, doi:10.48057/hematologa.v29i1.639.